Health costs associated with dementia are over EUR 55 billion per year in Europe alone, which will rise with an increasing European elderly population. The EU-funded NEUROPRO project has elucidated the role of prolyl oligopeptidases (PREPs) in neurodegenerative disorders (NDs) to restore normal function and find novel targets for therapy.
Further information: cordis.europa.eu